Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
EHRA 24: A Substudy of NOAH-AFNET 6
Author(s): Julius Nikorowitsch Added: 3 days ago
EHRA 24 - We are joined onsite by Dr Julius Nikorowitsch (University Heart and Vascular Centre Hamburg (UHZ), DE) to outline the impact of age, sex, cardiovascular comorbidities, and kidney function on outcomes with oral anticoagulation therapy in patients with device-detected atrial fibrillation in a substudy of the NOAH-AFNET 6 trial (NCT02618577).The substudy consisted of 2534 patients from… View more

Electrophysiology & Arrhythmia
Harry Crijns
Research Area(s) / Expertise:
Harry Crijns is a cardiologist with a specialization in cardiac arrhythmias. Dr Crijns obtained a PhD in 1993 on the medical treatment of atrial fibrillation (AF) and has since then achieved significant improvements in treatment through the introduction of care innovation and research by introducing risk scores CHA2DS2-VASc, HAS-BLED and the HATCH score. Dr Crijns is a member of the AER… View more
Fully Digital Self-Screening for Atrial Fibrillation with Patch Electrocardiogram
Author(s): Edvard Liljedahl Sandberg , Dominik Linz , Dan Atar Added: 11 months ago
Dr Dominik Linz (Maastricht University Medical Center+, NL) is joined by Dr Dan Atar (University of Oslo, NO) and Dr Edvard Sandberg (Sorlandet Hospital, NO) to discuss their February 2023 article published in EP Europace, 'Fully digital self-screening for atrial fibrillation with patch electrocardiogram'. Dr Sandberg presents a summary of the findings of this trial, outlining the current global… View more

Electrophysiology & Arrhythmia
AFSymposium 24: Impact of LAPW Ablation During PFA for Persistent AF
Author(s): Mohit K Turagam Added: 2 months ago
AF Symposium 2024 – In this interview, investigator Dr Mohit K Turagam (Icahn School of Medicine at Mount Sinai, US) discusses the findings of a sub-study of the MANIFEST-PF registry.The study investigated the impact of left atrial posterior wall ablation during pulsed field ablation (PFA) for persistent atrial fibrillation.Questions1. What is the MANIFEST-PF registry?2. What is the importance of… View more

Electrophysiology & Arrhythmia
Anticoagulation in Atrial Fibrillation – Current Concepts
Author(s): Demosthenes G Katritsis , Bernard J Gersh , A John Camm Added: 3 years ago
Thrombotic material in atrial fibrillation(AF) usually develops in the left atrial appendage as a result of decreased flow and stasis, possible endothelial dysfunction and a hypercoagulable state as indicated by increased fibrinogen, D-dimer, thromboglobulin and platelet factor 4 levels.1 In the Framingham Heart Study, the percentage of strokes attributable to AF increases steeply from 1.5 % in… View more

Anticoagulation

Standards & Guidelines
Author(s): Tze-Fan Chao , Chern-En Chiang , Shih-Ann Chen Added: 3 years ago
Burden of Atrial Fibrillation Atrial fibrillation (AF) is the most common sustained arrhythmia in clinical practice, accounting for approximately one-third of hospitalisations for cardiac rhythm disturbances.1 Between 1980 and 2000, the age-adjusted incidence of AF significantly increased from 3.04 to 3.68 per 1,000 person-years in the US.2 The prevalence of AF was lower among African Americans… View more

Electrophysiology & Arrhythmia

Prevention & Chronic Conditions
Non antivitamins K Oral Anti-Coagulants - Gheorghe Andrei Dan
Author(s): Gheorghe-Andrei Dan Start date: Mar 08, 2016

Anticoagulation
Hybrid Ablation – AF and Beyond
Added: 12 months ago
Under the expert moderation of Prof Harry Crijns(Maastricht, NL), a leading international faculty comprising Prof Carlo de Asmundis(Brussels, BE), Prof Mark La Meir(Brussels, BE) and Dr Ashley Nisbet(Bristol, UK) examine which arrhythmias could benefit from a hybrid approach, review the practical implementation of hybrid ablation in IST, and consider learnings from persistent and long-standing AF… View more

Electrophysiology & Arrhythmia
Artificial Intelligence for the Detection and Treatment of Atrial Fibrillation
AI in AF

Article

Author(s): David M Harmon , Ojasav Sehrawat , Maren Maanja , et al Added: 1 year ago

Electrophysiology & Arrhythmia

Digital Health
ACC 22: Results from the PACIFIC AF Trial
Author(s): Manesh R Patel Added: 2 years ago
In this short interview from our coverage of ACC.22 late-breaking trials, Dr Manesh Patel (Duke Heart Center, US) discusses the multicentre, randomised, double-blind PACIFIC-AF trial (Bayer)(NCT04218266). The trial sought to determine the efficacy of the oral FXIa inhibitor asundexian and evaluate the safety of the drug, compared to the non-vitamin K oral anticoagulant (NOAC) apixaban, in… View more

Anticoagulation

Electrophysiology & Arrhythmia